Sino Biological ProPure™ Endotoxin-Free Proteins: The ‘Invisible Guardian’ of Biopharmaceuticals
It may happen that after months of meticulous handling, your cells suddenly exhibit unexplained behaviour, or in the middle of crucial pharmacodynamic studies, your mouse models spontaneously develop fever and systemic inflammation. The culprit behind these problems may well be that invisible ‘silent killer’: endotoxin. Endotoxin originates from lipopolysaccharide (LPS) in the cell walls of gram-negative bacteria. Even in trace amounts, it can undermine valuable biological products. Excessive endotoxin not only may cause severe adverse reactions but also increases clinical risks and regulatory compliance pressures. Endotoxin-free recombinant proteins are the key to unlocking this challenge.
What are the potential risks of endotoxin?
The dangers posed by endotoxin (LPS) are often insidious and alarming. LPS can induce systemic inflammatory responses and neuroinflammation in animals, thereby interfering with experimental results and potentially rendering preclinical data invalid. Even more troublesome is that endotoxin-contaminated recombinant proteins, through their immunostimulatory and cytotoxic effects, subtly alter cellular behaviour, leaving researchers puzzled: Are the observed results due to the candidate drug itself or to ‘noise’ caused by impurities?
Endotoxin is a common contaminant in protein production. Even in small amounts, it can trigger strong immune responses, interfere with experimental results, and compromise patient safety—particularly in sensitive applications such as immunology, cell and gene therapy, and vaccine production. Therefore, Endotoxin-free proteins are essential for ensuring the accuracy, safety, and regulatory compliance of experiments in sensitive biological and pharmaceutical applications.
The firsthand experience of a biopharmaceutical researcher confirms this: “In our pharmacodynamics studies, we needed to inject recombinant proteins as candidate therapeutic drugs into mouse models. Sino Biological’s endotoxin-free protein products were critical to the success of the experiment. The experimental mice showed no signs of pyrogenic responses or systemic toxicity, which ensured that the observed effects were entirely due to the biological activity of the proteins rather than non-specific inflammation caused by impurities or endotoxin.”
Excellence built on ultra-low endotoxin
Endotoxin testing methods and release standards are based on pharmacopeial specifications. For instance, according to the United States Pharmacopeia (USP) <85> endotoxin testing standard, a product’s endotoxin level must be below 0.5 EU/mL to be considered acceptable and safe. However, this standard is merely the ‘baseline’ for endotoxin-free recombinant proteins.
The ProPure™ series produced by Sino Biological’s Center for Bioprocessing (C4B) in Texas, achieves endotoxin levels as low as 0.05 EU/mg, with some products reaching 0.01 EU/mg—exceeding industry standards by more than tenfold. Endotoxin-free proteins provide a more reliable choice for preclinical research, precise cellular experiments, and high-sensitivity detection assays.
How is endotoxin controlled to the utmost degree?
Sino Biological ensures ultra-low endotoxin levels in protein production through the following process upgrades:
Prevention at the Source: From plasmid construction to buffer preparation, we implement rigorous quality control systems, using endotoxin-free plasmids and buffers, low endotoxin-binding plastic containers, and following regular Clean-in-Place (CIP) principles.
Environmental Isolation: Our C4B has adhered to the ‘E. coli-free’ principle from its inception. We do not use E. coli expression systems and do not introduce any E. coli or endotoxins, physically eliminating contamination pathways completely.
Dual Detection: We employ both LAL (Limulus Amebocyte Lysate) and rFc (recombinant Factor C) methods to detect endotoxin concentration, strictly monitoring endotoxin levels and ensuring that every batch of data is traceable and reliable.
Based on this rigorous ‘Prevention-Isolation-Detection’ triple-control system, Sino Biological can reduce endotoxin risk to detection limits, providing customised ultra-low endotoxin protein products and services for drug development and preclinical research to meet stringent quality requirements.
Sino Biological employs advanced technological processes and equipment to produce ProPure™ endotoxin-free proteins, safeguarding the safety of biopharmaceuticals. Excellence Built on Ultra-Low Endotoxin. ProPure™ endotoxin-free proteins clear hidden obstacles for scientific research and build a solid line of defence for innovative biopharmaceutical development.
Sino Biological maintains rigorous quality control throughout the entire production process to minimise endotoxin to the lowest level. ProPure™ endotoxin-free proteins, with an ultimate standard as low as 0.05 EU/mg, protect every step of your research. Additionally, C4B offers customised endotoxin-free protein services to meet the higher endotoxin control requirements in preclinical and drug development.
